Director, Clinical Pharmacology
Gilead Sciences
Foster City, California, United States
Dr. Justin Feigelman is currently Director, Clinical Pharmacology at Gilead Sciences, leading the development of Quantitative Systems Pharmacology (QSP) models in the clinical setting. He has worked in the QSP space for more than 8 years, contributing to model development in the areas of immunology, inflammation, oncology and virology at Genentech, Regeneron and Gilead. Dr. Feigelman is further interested in the development of methods and tools to support QSP modeling, including the development of gQSPSim while at Genentech which provides an integrated tool for developing, maintaining and distributing QSP models using MATLAB SimBiology.
Disclosure information not submitted.
An immune booster: QSP modeling to advance the treatment for autoimmune diseases
Sunday, October 19, 2025
2:00 PM - 3:30 PM MDT
Integrated systems pharmacology modeling of severe asthma and the IL-33/ST2 pathway
Sunday, October 19, 2025
2:00 PM - 2:20 PM MDT
Panel - An immune booster: QSP modeling to advance the treatment for autoimmune diseases
Sunday, October 19, 2025
3:20 PM - 3:30 PM MDT